Blood Tests Can Help Physicians Correctly Diagnose Alzheimer's In Low-Resource Environments
By LabMedica International staff writers Posted on 25 Apr 2023 |
In low-resource communities, which are home to 58% of the global dementia population, there is often a shortage of specialists capable of diagnosing Alzheimer's disease or access to brain imaging equipment for confirmation. Although spinal fluid biomarkers can confirm a diagnosis, patients might be hesitant to undergo a lumbar puncture to extract cerebrospinal fluid. Recently, blood-based biomarkers have emerged as a viable alternative, performing nearly as well as spinal fluid biomarkers in identifying Alzheimer's disease. However, limited research has been conducted in low-resource settings to evaluate the accuracy of these blood tests for diagnosing Alzheimer's disease. Now, neurologists are investigating a combination of blood tests and memory assessments to enhance diagnostic accuracy in these environments.
In a collaborative study between Columbia University (New York, NY, USA) and local physicians, 746 older adults (average age of 71) were recruited from the Dominican Republic and the Dominican community in northern Manhattan. Participants underwent extensive neurological and cognitive evaluations, with a panel of Columbia neurologists specializing in Alzheimer's diagnosis analyzing the results to determine if participants had Alzheimer's, other forms of dementia, or normal cognitive aging. Blood samples were collected to measure Alzheimer's blood-based biomarkers. Just over 20% of participants were clinically diagnosed with Alzheimer's, and their blood tests revealed elevated levels of Alzheimer's biomarkers, including phosphorylated tau, neurofilament light chain, and glial fibrillary acidic protein.
Interestingly, the blood-based tests also appeared to detect early biological signs of Alzheimer's before symptoms manifest. Approximately 20% of participants who were not diagnosed with Alzheimer's based on memory and cognitive assessments displayed elevated levels of the aforementioned biomarkers in their blood. This suggests that blood tests may be a sensitive indicator of preclinical Alzheimer's disease, potentially benefiting early intervention efforts as preventive strategies become more readily available. Further research is needed to determine the clinical applications of blood-based biomarker tests, as they are not currently available outside of research studies.
“Alzheimer’s disease is one form of dementia and as more treatments emerge, developing an accurate blood test will be essential in finding people who will benefit from treatment, particularly those who lack access to more advanced diagnostic tools,” said Richard Mayeux, MD, chair of the Department of Neurology at Columbia University Vagelos College of Physicians and Surgeons and one of the study’s senior authors.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans